Evidence map›Paper›PMID 33208828›Full record

ArticleScientific reports2020

Prediagnostic serum 25-hydroxyvitamin D and melanoma risk.

Jo S Stenehjem, Nathalie C Støer, Reza Ghiasvand, Tom K Grimsrud, Ronnie Babigumira, Judy R Rees, Lill Tove Nilsen, Bjørn Johnsen, Per M Thorsby, Marit B Veierød and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Jo S StenehjemDepartment of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Blindern, P.O. Box 1122, 0317, Oslo, Norway. jo.stenehjem@kreftregisteret.no.
Nathalie C StøerDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Reza GhiasvandDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Tom K GrimsrudDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Ronnie BabigumiraDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Judy R ReesNew Hampshire State Cancer Registry, Lebanon, NH, USA.
Lill Tove NilsenNorwegian Radiation and Nuclear Safety Authority, Østerås, Norway.
Bjørn JohnsenNorwegian Radiation and Nuclear Safety Authority, Østerås, Norway.
Per M ThorsbyHormone Laboratory, Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Marit B VeierødDepartment of Biostatistics, Oslo Centre for Biostatistics and Epidemiology, University of Oslo, Blindern, P.O. Box 1122, 0317, Oslo, Norway.
Trude E RobsahmDepartment of Research, Cancer Registry of Norway, Oslo, Norway.
Cancer Registry of Norway · NONorwegian Radiation and Nuclear Safety Authority · NOOslo University Hospital · NOUniversity of Oslo · NONew Hampshire Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies of serum 25-hydroxyvitamin D (25(OH)D) in relation to melanoma have shown conflicting results. We conducted a nested case-control study of 708 cases and 708 controls, using prediagnostically collected serum, to study 25(OH)D and melanoma risk in the population-based Janus Serum Bank Cohort. Stratified Cox regression was used to estimate hazard ratios (HRs) with 95% confidence intervals (CIs) adjusted for ultraviolet radiation (UVR) indicators and stratified by ambient UVB of residence and body mass index (BMI). Non-linear associations were studied by restricted cubic splines. Missing data were handled with multiple imputation by chained equations. We found an HR of melanoma risk of 1.01 (95% CI: 0.99, 1.04) and an HR

Indexed as

AdultAgedBody Mass IndexCase-Control StudiesFemaleHumansMaleMelanomaMiddle AgedNorwayRisk FactorsSkin NeoplasmsUltraviolet RaysVitamin DYoung Adult25-hydroxyvitamin DVitamin D

Identifiers

PMID33208828
PMCPMC7676247
OpenAlexW3105557868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.